about
Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases.The influence of hepatitis B and C virus coinfection on liver histopathology in children.A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.Assessment of pain, acceptance of illness, adjustment to life with cancer, and coping strategies in colorectal cancer patientsComposition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression.Diagnosis of hepatitis C virus infection in pregnant women in the healthcare system in Poland: Is it worth the effort?Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression.Predictors of Liver Disease Severity in Children with Chronic Hepatitis B.Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: results of a prospective single-centre study.Hepatocellular-cholestatic liver injury due to amoxycillin-clavulanic acid combination.Hepatitis G virus coinfection in chronic hepatitis B and C patients in Poland.Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland.Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis.Treatment of chronic hepatitis B with lamivudine in renal allograft recipientsHistopathological evaluation of liver biopsy specimens in children with chronic hepatitis B
P50
Q33601691-59C29403-D0E9-4EC7-869C-AC53616EBAA1Q33775587-A16EB9A4-CDC3-4530-861D-8B7925C2BC0BQ35100262-7F9277F6-2E7B-4EF4-80B9-81FE3D0DD390Q36241388-DEA6AA9F-5619-41ED-A8FB-7F5F2327013FQ37026978-32C256BC-41E3-49F9-B157-D5F625EF15E5Q37301391-D5176848-0E92-4655-95D6-38C52E71C284Q37605651-91C812CF-3C9C-4821-BC7D-83A962A077ACQ37613361-FFF40A97-A5F2-4C1E-B942-1F4E7CB478F1Q39388899-85CDA7D4-D59B-4F5D-B142-B0540EF5017BQ42033362-166AE418-9B33-4841-BB21-5149CAAEA99DQ42200376-6B4DF07F-53F3-4F9D-88DE-5D8BBC9F2D57Q42280298-DE23D17C-3605-4B0C-9E37-566F8ABAEBF2Q42987596-257133D7-6C7E-457A-AAED-67ADB6226D30Q42996232-B1CF04C2-EEE6-4BCA-AD30-32F068DAE558Q43434701-609CD9A3-35AD-410D-B704-83EB473EAA36Q74339772-16FBFA2F-94B3-4BC8-B680-C312DEAE30EEQ81644722-B321D63D-D8A4-4871-9F27-99CD26AA7770
P50
description
Polish researcher
@en
polski naukowiec
@pl
taighdeoir Polannach
@ga
wetenschapper
@nl
name
Bożena Walewska-Zielecka
@ast
Bożena Walewska-Zielecka
@ca
Bożena Walewska-Zielecka
@de
Bożena Walewska-Zielecka
@en
Bożena Walewska-Zielecka
@es
Bożena Walewska-Zielecka
@fr
Bożena Walewska-Zielecka
@ga
Bożena Walewska-Zielecka
@gl
Bożena Walewska-Zielecka
@it
Bożena Walewska-Zielecka
@nl
type
label
Bożena Walewska-Zielecka
@ast
Bożena Walewska-Zielecka
@ca
Bożena Walewska-Zielecka
@de
Bożena Walewska-Zielecka
@en
Bożena Walewska-Zielecka
@es
Bożena Walewska-Zielecka
@fr
Bożena Walewska-Zielecka
@ga
Bożena Walewska-Zielecka
@gl
Bożena Walewska-Zielecka
@it
Bożena Walewska-Zielecka
@nl
altLabel
Bozena Walewska-Zielecka
@en
Bożena Hanna Walewska-Zielecka
@pl
prefLabel
Bożena Walewska-Zielecka
@ast
Bożena Walewska-Zielecka
@ca
Bożena Walewska-Zielecka
@de
Bożena Walewska-Zielecka
@en
Bożena Walewska-Zielecka
@es
Bożena Walewska-Zielecka
@fr
Bożena Walewska-Zielecka
@ga
Bożena Walewska-Zielecka
@gl
Bożena Walewska-Zielecka
@it
Bożena Walewska-Zielecka
@nl
P1006
P214
P1006
P1053
U-2058-2018
P1412
P1559
Bożena Walewska-Zielecka
@pl
P21
P214
P27
P31
P3124
P496
0000-0001-6828-6912
P7859
viaf-166569392